| Single-dose psilocybin for a treatment-resistant episode of major depression GM Goodwin, ST Aaronson, O Alvarez, PC Arden, A Baker, JC Bennett, ... New England Journal of Medicine 387 (18), 1637-1648, 2022 | 476 | 2022 |
| Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice LL Carpenter, PG Janicak, ST Aaronson, T Boyadjis, DG Brock, IA Cook, ... Depression and anxiety 29 (7), 587-596, 2012 | 431 | 2012 |
| Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized … SH Lisanby, MM Husain, PB Rosenquist, D Maixner, R Gutierrez, ... Neuropsychopharmacology 34 (2), 522-534, 2009 | 394 | 2009 |
| A 5-year observational study of patients with treatment-resistant depression treated with vagus nerve stimulation or treatment as usual: comparison of response, remission, and … ST Aaronson, P Sears, F Ruvuna, M Bunker, CR Conway, DD Dougherty, ... American Journal of Psychiatry 174 (7), 640-648, 2017 | 320 | 2017 |
| A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a … DL Dunner, ST Aaronson, HA Sackeim, PG Janicak, LL Carpenter, ... The Journal of clinical psychiatry 75 (12), 12379, 2014 | 197 | 2014 |
| International randomized-controlled trial of transcranial direct current stimulation in depression CK Loo, MM Husain, WM McDonald, S Aaronson, JP O'Reardon, ... Brain stimulation 11 (1), 125-133, 2018 | 194 | 2018 |
| Vagus nerve stimulation therapy randomized to different amounts of electrical charge for treatment-resistant depression: acute and chronic effects ST Aaronson, LL Carpenter, CR Conway, FW Reimherr, SH Lisanby, ... Brain stimulation 6 (4), 631-640, 2013 | 173 | 2013 |
| Efficacy and safety of low-field synchronized transcranial magnetic stimulation (sTMS) for treatment of major depression AF Leuchter, IA Cook, D Feifel, JW Goethe, M Husain, LL Carpenter, ... Brain stimulation 8 (4), 787-794, 2015 | 115 | 2015 |
| Clinical outcomes in a large registry of patients with major depressive disorder treated with Transcranial Magnetic Stimulation HA Sackeim, ST Aaronson, LL Carpenter, TM Hutton, M Mina, K Pages, ... Journal of Affective Disorders 277, 65-74, 2020 | 111 | 2020 |
| Brain state and body position: a time-lapse video study of sleep ST Aaronson, S Rashed, MP Biber, JA Hobson Archives of General Psychiatry 39 (3), 330-335, 1982 | 105 | 1982 |
| Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study M Tohen, E Vieta, GM Goodwin, B Sun, JD Amsterdam, M Banov, ... J Clin Psychiatry 69 (11), 1776-89, 2008 | 99 | 2008 |
| Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder TA Pigott, A Prakash, LM Arnold, ST Aaronson, CH Mallinckrodt, ... Current medical research and opinion 23 (6), 1303-1318, 2007 | 99 | 2007 |
| Can medication free, treatment-resistant, depressed patients who initially respond to TMS be maintained off medications? A prospective, 12-month multisite randomized pilot study NS Philip, DL Dunner, SM Dowd, ST Aaronson, DG Brock, LL Carpenter, ... Brain stimulation 9 (2), 251-257, 2016 | 91 | 2016 |
| Difficult-to-treat depression: a clinical and research roadmap for when remission is elusive AJ Rush, ST Aaronson, K Demyttenaere Australian & New Zealand Journal of Psychiatry 53 (2), 109-118, 2019 | 90 | 2019 |
| The assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form (ATHF-SF) HA Sackeim, ST Aaronson, MT Bunker, CR Conway, MA Demitrack, ... Journal of psychiatric research 113, 125-136, 2019 | 87 | 2019 |
| Chronic vagus nerve stimulation significantly improves quality of life in treatment-resistant major depression CR Conway, A Kumar, W Xiong, M Bunker, ST Aaronson, AJ Rush The Journal of Clinical Psychiatry 79 (5), 22269, 2018 | 77 | 2018 |
| Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life GM Goodwin, ST Aaronson, O Alvarez, M Atli, JC Bennett, M Croal, ... Journal of Affective Disorders 327, 120-127, 2023 | 69 | 2023 |
| Potential role of the combination of galantamine and memantine to improve cognition in schizophrenia MM Koola, RW Buchanan, A Pillai, KJ Aitchison, DR Weinberger, ... Schizophrenia research 157 (1-3), 84-89, 2014 | 69 | 2014 |
| Left prefrontal transcranial magnetic stimulation for treatment-resistant depression in adolescents: a double-blind, randomized, sham-controlled trial PE Croarkin, AZ Elmaadawi, ST Aaronson, GR Schrodt Jr, RC Holbert, ... Neuropsychopharmacology 46 (2), 462-469, 2021 | 66 | 2021 |
| Clinical research challenges posed by difficult-to-treat depression AJ Rush, HA Sackeim, CR Conway, MT Bunker, SD Hollon, ... Psychological medicine 52 (3), 419-432, 2022 | 54 | 2022 |
Linda CarpenterProfessor, Brown Department of Psychiatry and Human Behavior; Butler Hospital在 brown.edu 的电子邮件经过验证
